Virginia Commonwealth University Medical Center has become one of the nation’s first medical centers to complete the Pulmonary Hypertension Association’s new accreditation program for Pulmonary Hypertension Care Centers. The goal of the program is to improve the outcomes of patients with pulmonary hypertension, a debilitating disease of the lungs that affects the functioning of the heart and can lead to right heart failure.
With symptoms that include breathlessness, fatigue, dizziness and chest pain, many pulmonary hypertension patients will see three or more physicians before they receive an accurate diagnosis. The survival rate for PH patients who go untreated is less than three years.
“We’re pleased that health care centers across the country are undergoing the rigorous review process to receive the special accreditation in the coming months,” said Murali Chakinala, M.D., from the Washington University in St. Louis School of Medicine and member of PHA’s Pulmonary Hypertension Association Oversight Committee. “In addition to providing lifesaving care for patients, these specialty care centers are a valuable resource for medical professionals, health insurers and families of people living with PH.”
“VCU Medical Center will improve the lives of more patients who know they have PH and many who have it and don’t know it.”
“There is an urgent need for medical institutions to accurately diagnose, treat and provide support for PH patients,” said Daniel C. Grinnan, M.D., associate professor of the Division of Pulmonary Disease and Critical Care Medicine in the Department of Internal Medicine at VCU Medical Center. “Our hope is that the PHA accreditation raises our profile to help us connect with health care professionals throughout our community to ensure that more people living with PH receive the right diagnosis early and accurately and that they will get the very best care available.”